Afrocentric InvestmentJSE:ACT 52 Days Payable is 112.79 as of Dec. 2025, which is 73% above its 10-year median of 65.02. GuruFocus rates JSE:ACT with a GF Score™ of 52/100 and a GF Value™ of R2.09 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 608 Healthcare Providers & Services companies, Afrocentric Investment ranks better than 50.66% on this metric.
The historical rank and industry rank for Afrocentric Investment's Days Payable or its related term are showing as below:
JSE:ACT'
s Days Payable Range Over the Past 10 Years
Min: 41.64 Med: 65.02 Max: 122.29
Current: 58.66
During the past 13 years, Afrocentric Investment's highest Days Payable was 122.29. The lowest was 41.64. And the median was 65.02.
JSE:ACT's Days Payable is ranked better than 50.66% of 608
companies
in the Healthcare Providers & Services industry
Industry Median: 58.08
vs JSE:ACT: 58.66
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Afrocentric Investment's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Afrocentric Investment Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Afrocentric Investment's Days Payable distribution charts can be found below:
* The bar in red indicates where Afrocentric Investment's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Afrocentric Investment's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Afrocentric Investment (JSE:ACT) has a Days Payable of 112.79 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Afrocentric Investment and its competitors. This is 73% above median its historical median of 65.02. Over the past decade, Afrocentric Investment's Days Payable has ranged from 41.64 to 122.29. According to the industry distribution chart, Afrocentric Investment ranks #300 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 49.3%.
Is Afrocentric Investment's Days Payable too high?
Afrocentric Investment's current Days Payable of 112.79 is 73% above median its 10-year median of 65.02. Over the past 10 years, this metric has ranged from a low of 41.64 to a high of 122.29. The Healthcare Providers & Services industry median Days Payable is 58.08. Afrocentric Investment's value of 112.79 is 94.2% above this industry median. Based on the distribution chart, Afrocentric Investment ranks #300 out of 608 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Afrocentric Investment has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Afrocentric Investment's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Afrocentric Investment ranks #300 out of 608 companies for Days Payable. This puts Afrocentric Investment in the upper half of its industry. The industry median Days Payable is 58.08. Afrocentric Investment's value of 112.79 is 94.2% above this benchmark. Historically, Afrocentric Investment's own Days Payable has ranged from 41.64 to 122.29 over the past decade. While the company's 10-year median is 65.02 vs. the industry median of 58.08, Afrocentric Investment has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.08, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Afrocentric Investment's current Days Payable of 112.79 is 94.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Afrocentric Investment and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Afrocentric Investment's current Days Payable is 112.79, which is 73% above median its own 10-year median of 65.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Afrocentric Investment stock overvalued right now?
Based on GuruFocus' analysis, Afrocentric Investment (JSE:ACT) is currently considered Possible Value Trap. The stock's GF Value™ is R2.09, compared to a current price of R0.79 — trading 62.2% below its estimated fair value. The current Days Payable is 112.79, which is 73% above median its 10-year median of 65.02 and 94.2% above the Healthcare Providers & Services industry median of 58.08. Afrocentric Investment's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Afrocentric Investment (JSE:ACT), the current Days Payable is 112.79 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Afrocentric Investment (JSE:ACT) Overvalued in 2026?
Based on GuruFocus' analysis, Afrocentric Investment stock appears to be undervalued.
The current stock price of R0.79 is trading 62.2% below its estimated GF Value™ of R2.09.
GuruFocus considers Afrocentric Investment to be Possible Value Trap.
Key valuation signals for JSE:ACT:
Days Payable: 112.79 (73% above median its 10-year median of 65.02)
GF Value™: R2.09 vs. price of R0.79 (62.2% below fair value)
Industry Position: 94.2% above the Healthcare Providers & Services median (#300 of 608)
No single metric tells the full story. See the JSE:ACT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Afrocentric Investment Corp Ltd is an investment holding company providing specialised services and products to the public and private healthcare sectors. It focuses on making quality healthcare accessible and affordable to members and beneficiaries, with the principal objective of ensuring the delivery of efficient health management services and the distribution of quality products. Its business segments include Healthcare SA, comprising medical scheme administration and health risk management services; Healthcare Retail, comprising pharmaceutical sales and services; Healthcare Africa, comprising healthcare services outside South Africa in Namibia and Mauritius; and IT-related services predominantly within South Africa. It operates across South Africa, Botswana, Mauritius, and Namibia.
52GF Score
Get the complete analysis for JSE:ACT
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:ACT has been successfully added to your 
